Member Info for stephen11

Great RNS.

Kodal Minerals’ Bougouni Lithium Project was officially opened by Mali’s President, confirming full operational status, state backing, and imminent first exports — a strong signal of stability after recent unrest fears.

Roughly - at 125,000 tpa of 5.5 % Li₂O concentrate, the project implies roughly US $33–40 million in annual revenue attributable to Kodal at current spodumene prices, marking its transition into a genuine cash-generating producer.

GLA.

Stephen11.

I agree Crober - no imminent need for a fundraise, although an extra £1m will only take us to the end of March 2026, assuming the monthly cash burn has been reduced to circa £350,000 per month.

We need to be realistic - nothing wrong with getting a small rise at a higher SP around this time to get us to EBIDTA positive.

Genedrive announces that its MT-RNR1 ID Kit has been implemented at Dublin’s Rotunda Hospital NICU — its first confirmed international adoption outside the UK — funded initially by the Rotunda Foundation.

- This marks further real-world validation of the technology and signals growing clinical traction, which could strengthen confidence ahead of potential funding news and wider commercial rollout.

Good news all round.

Expect 1.5p when DN's £1m loan is agreed - this also paves the way for a fundraise at a more respectable SP. E.g., 1.2 to 1.3p - i could live with that.

GLA.

Stephen11.

When is the first shipmate due to leave the port?

And

How many tonnes will the first shipment consist of?

Thanks.

Yes, there’s unrest near Bamako, but its 180KM away — our mine is safe, running, exporting, and even hosting the president today.

Why all the bedwetting?

And as the old saying goes 'Necessity is the mother of invention'

I'd say a deal will be done with Mr Nugent and the £1m loan will be announced in due course - the boards salaries depend on it.

On that note, i hope DN plays hardball with the board. A salary deferral or significant reduction for the CEO and CFO until we are EDIDTA positive would be one carrot.

The loan would give the board 5 months to negotiate a placing on better terms.

With near term news on multiple fronts: Scotland, Saudi Arabia, NHS, etc. 1.5p might be a better place to raise at early next year.

GLA.

Stephen11.

Hi folks,

Just my spin on things as a holder for over 5 years.

- For the board: a face-saving development after EGM defeat; suggests they’ve accepted Nugent’s influence.

- For Nugent: gaining credibility as a potential white knight shareholder. I'd say he's signed an NDA.

- For the market: reduces near-term bankruptcy risk, making GDR investable again for speculative traders and possibly small institutions.

- If completed, £1m buys 3–4 months of extra runway (beyond end-2025 cash) — potentially to Q1/Q2 2026, depending on burn rate.

- It’s a non-dilutive bridge, which is very attractive compared with prior deep-discount placings.

- It also potentially repositions Nugent as a key strategic partner, not just a vocal investor.

- This could stabilise sentiment while longer-term funding or commercial deals are negotiated (Saudi Arabia, NHS, or US FDA developments).

Great news all round.

GLA.

Stephen11.

I'm not sure Junior - that's a good question.

The market seems to have positive sentiment at the moment - maybe people buying in on the possibility of a less dilutive funding option.

The Saudi MOU seems to have been a positive aswell.

We haven't heard from DN in a while?

My guess is that he's signed an NDA to have a closer look under the bonnet.

Could be wrong - who knows.

Something is afoot - i didn't expect +50% today.

The Saudi news is good, though only a MOU - which suggests future pilot studies and national rollout - so still jam tomorrow.

I expected 20-25% today, although i'm not complaining.

Lionel1 - great find

Are they using a GDR platform for this test in GP surgeries?…I hope so 🤞.

Too much of a coincidence that Prof. Bill Newman from Manchester University is involved 🤔

Hi Folks - just my take on this:

- The goal: a potential national implementation of Genedrive’s test under the “Generations Hear” programme — a large-scale initiative to protect newborns from antibiotic-induced hearing loss.

- This directly aligns with Saudi Vision 2030, a high-profile government plan with heavy funding for health innovation and localisation of biotech.

- In short: GDR’s distributor now has government-level backing to pilot Genedrive’s technology — a clear validation step and a possible route to national adoption.

- The link to Vision 2030 implies government-scale funding potential — not small hospital trials.

- Even a modest pilot could de-risk future fundraises or attract strategic investors, since it demonstrates overseas demand.

- A much better RNS: It’s optimistic, clinical, and professional — a good sign that management are refocusing on business progress rather than shareholder politics.

GLA,

Stephen11.

At last - some good news!

Thanks for sharing.

Hi Eureka,

Sincere thanks for your tenacity and perseverance in chasing up more information regarding the implementation guide for CYP2C19.

Makes you wonder though if the BOD are chasing the likes of this important issue up with the same vigour!? I suspect not, based on previous communication and GDR's history of missed deadlines, which is all part of a bigger issue.

GLA,

Stephen11.

No debt Ak - one positive anyway 😊

As a wise man once said.

I’m hoping the board can secure non-dilutive funding in the near future.

This is not the time for poor communication either. Silence 🤐 will make the markets uncertain.

I agree Lionel - we need to be EDITDA positive, get £8m a year from NHS, and FDA to get anywhere near 5p. Maybe by 2027.

1-1.5p is realistic in the short term if we can secure non-dilutive funding.

Next year 2-3p if NHS National Commissioning happens.

Out of the fire 🔥 we shall rise again.

Interesting point Busicat - if you look at GDRs 1 year graph the highest price paid would have been almost 3p in November 2024.

Might DN have been averaging down then?

In which case any takeover would be at a higher sp, if I’m interpreting the rules correctly?…happy to be corrected?

Another possibility for the low vote turnout is that a high number of PI's might have extremely high average purchase prices and didn't bother to vote.

For them this share is in the proverbial bottom drawer.

And i don't mean a 2 or 5p average purchase price.

I remember one poor chap from back in the day had a £2.00 average....he's probably written these shares off.